Benefits of Continuous Positive Airway Pressure (CPAP) During Radiation Therapy: A Prospective Trial.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 08 2021
Historique:
received: 05 01 2021
revised: 18 03 2021
accepted: 23 03 2021
pubmed: 10 5 2021
medline: 24 9 2021
entrez: 9 5 2021
Statut: ppublish

Résumé

This study aimed to study the impact of continuous positive airway pressure (CPAP) on chest anatomy and tumor motion in patients receiving radiation therapy. Patients with primary or secondary lung tumors, left-sided breast cancer, or liver metastases referred for radiation therapy were trained to breathe with a CPAP device using a face mask to a maximal pressure of 15 cm H Forty-nine patients were enrolled, of whom 6 withdrew consent before simulation and 3 withdrew because of discomfort. Thus, a total of 40 patients were analyzed. Twenty-seven patients (67.5%) were treated with CPAP based on confirmation of the volumetric or dosimetric benefit of CPAP. Mean lung volume increased by 37% (P < .001). The mean augmentation was 1283 ± 1128 cm In this prospective trial, the use of CPAP was associated with significant volumetric and dosimetric benefits compared with FB. CPAP was safe, simple to implement, and well tolerated by most patients, and it should be studied further as a method to reduce the risk of lung and heart toxicity.

Identifiants

pubmed: 33965269
pii: S0360-3016(21)00306-0
doi: 10.1016/j.ijrobp.2021.03.044
pii:
doi:

Types de publication

Clinical Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1466-1472

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Galia Jacobson (G)

Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yaacov Richard Lawrence (YR)

Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Center for Translational Research in Radiation Oncology, Tel Hashomer, Israel.

Sarit Appel (S)

Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ilana Weiss (I)

Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Maoz Ben Ayun (M)

Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Merav Akiva Ben-David (M)

Medical School for International Health, Ben-Gurion University of the Negev Beer Sheva, Israel; Radiation Oncology Department, Assuta Medical Center, Tel Aviv, Israel.

Nir Peled (N)

Oncology Division and Cancer Center, Shaare Zedek Medical Center, Jerusalem, Israel.

Jeffrey D Goldstein (JD)

Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Noam Weizman (N)

Radiation Oncology, Hadassah Medical Center, Jerusalem, Israel.

Shira Galper (S)

Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Orit Kaidar-Person (O)

Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; GROW School for Oncology and Developmental Biology (Maastro), Maastricht University, Maastricht, The Netherlands.

Zvi Symon (Z)

Department of Radiation Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: Zvi.Symon@sheba.health.gov.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH